| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00210-009-0480-2 |
| P698 | PubMed publication ID | 20020280 |
| P50 | author | Elaine C Gavioli | Q48233244 |
| Remo Guerrini | Q39033652 | ||
| Morgana Moretti | Q41562938 | ||
| Carina Rodrigues Boeck | Q43259592 | ||
| P2093 | author name string | Girolamo Calo' | |
| Caroline Martinello | |||
| Adalberto A de Castro | |||
| Tiago Dos Santos Casagrande | |||
| P2860 | cites work | NMDA preconditioning protects against seizures and hippocampal neurotoxicity induced by quinolinic acid in mice | Q44961274 |
| Neuropeptide S produces antinociceptive effects at the supraspinal level in mice | Q46061905 | ||
| Persistent increase of alcohol-seeking evoked by neuropeptide S: an effect mediated by the hypothalamic hypocretin system | Q46074543 | ||
| Neuropeptide S produces hyperlocomotion and prevents oxidative stress damage in the mouse brain: a comparative study with amphetamine and diazepam. | Q46235953 | ||
| Neuropeptide S inhibits the acquisition and the expression of conditioned place preference to morphine in mice | Q46257663 | ||
| Differential appetite-related responses to central neuropeptide S in lines of chickens divergently selected for low or high body weight | Q46620419 | ||
| A detailed behavioral analysis of the acute motor effects of caffeine in the rat: involvement of adenosine A1 and A2A receptors | Q46736722 | ||
| Caffeine treatment regulates neuropeptide S system expression in the rat brain. | Q48391064 | ||
| Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake | Q48598758 | ||
| Peptide S is a novel potent inhibitor of voluntary and fast-induced food intake in rats | Q48883476 | ||
| The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists. | Q51082990 | ||
| SCH 58261 and ZM 241385 differentially prevent the motor effects of CGS 21680 in mice: evidence for a functional 'atypical' adenosine A(2A) receptor. | Q52166464 | ||
| Stimulatory effect of caffeine on the hypothalamo-pituitary-adrenocortical axis in the rat | Q69355024 | ||
| Direct autoradiographic localization of adenosine A2 receptors in the rat brain using the A2-selective agonist, [3H]CGS 21680 | Q69362137 | ||
| Intracerebroventricular injections in mice. Some methodological refinements | Q69669104 | ||
| Inhibitory and excitatory effects of adenosine antagonists on spontaneous locomotor activity in mice | Q73287325 | ||
| Synthesis and biological activity of human neuropeptide S analogues modified in position 5: identification of potent and pure neuropeptide S receptor antagonists | Q24643033 | ||
| Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice | Q24648353 | ||
| Neuropeptide S-mediated control of fear expression and extinction: role of intercalated GABAergic neurons in the amygdala | Q24655895 | ||
| Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor | Q24657522 | ||
| Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects | Q28277170 | ||
| Neuropeptide S facilitates spatial memory and mitigates spatial memory impairment induced by N-methyl-D-aspartate receptor antagonist in mice | Q28593529 | ||
| Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum | Q30945230 | ||
| Fine-tuning neuromodulation by adenosine | Q34023335 | ||
| Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration | Q34191271 | ||
| Caffeine as a psychomotor stimulant: mechanism of action. | Q34314690 | ||
| Antagonism of adenosine A2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens | Q34432262 | ||
| Combination of adenosine A1 and A2A receptor blocking agents induces caffeine-like locomotor stimulation in mice | Q34438493 | ||
| Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activation | Q34529762 | ||
| Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine | Q34558649 | ||
| Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain | Q34581145 | ||
| Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders | Q34756930 | ||
| Anxiolytic-like effect of neuropeptide S in the rat defensive burying | Q34827864 | ||
| Potentiation by tonic A2a-adenosine receptor activation of CGRP-facilitated [3H]-ACh release from rat motor nerve endings | Q35874244 | ||
| Neuropeptide S reinstates cocaine-seeking behavior and increases locomotor activity through corticotropin-releasing factor receptor 1 in mice | Q36221019 | ||
| Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor | Q37613582 | ||
| Pharmacological characterization of human and murine neuropeptide s receptor variants | Q40376643 | ||
| Tonic activation of A(2A) adenosine receptors unmasks, and of A(1) receptors prevents, a facilitatory action of calcitonin gene-related peptide in the rat hippocampus | Q41809750 | ||
| Immunohistochemical detection of A1 adenosine receptors in rat brain with emphasis on localization in the hippocampal formation, cerebral cortex, cerebellum, and basal ganglia | Q42478257 | ||
| Neuropeptide S selectively inhibits the release of 5-HT and noradrenaline from mouse frontal cortex nerve endings. | Q43097962 | ||
| Adenosine A(1) receptor-mediated inhibition of protein kinase A-induced calcitonin gene-related peptide release from rat trigeminal neurons. | Q43608494 | ||
| Anorexigenic effects of central neuropeptide S involve the hypothalamus in chicks (Gallus gallus). | Q44932465 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 153-160 | |
| P577 | publication date | 2009-12-19 | |
| P1433 | published in | Naunyn-Schmiedeberg's Archives of Pharmacology | Q1468251 |
| P1476 | title | Blockade of adenosine A2A receptor counteracts neuropeptide-S-induced hyperlocomotion in mice | |
| P478 | volume | 381 |
| Q83973711 | Effect of adenosine A2A receptor antagonist ZM241385 on amygdala-kindled seizures and progression of amygdala kindling |
| Q33927642 | Emerging country pharmacology: a 10-year perspective from Naunyn-Schmiedeberg's Archives of Pharmacology |
| Q38749596 | Identification of the first biased NPS receptor agonist that retains anxiolytic and memory promoting effects with reduced levels of locomotor stimulation. |
| Q50587410 | Modification of caffeine effects on the affect-modulated startle by neuropeptide S receptor gene variation. |
| Q92501438 | Neuropeptide S-initiated sequential cascade mediated by OX1, NK1, mGlu5 and CB1 receptors: a pivotal role in stress-induced analgesia |
Search more.